Amphastar Pharmaceuticals Inc logo

AMPH

Amphastar Pharmaceuticals Inc

$32.12

Earnings Summary

Revenue
$120.37Mn
Net Profits
$24.25Mn
Net Profit Margins
20.15%
PE Ratio
17.29

Highlights

Revenue:

Amphastar Pharmaceuticals Inc’s revenue jumped 16.84% since last year same period to $120.37Mn in the Q1 2022. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated -0.43% fall in its revenue since last 3-months.

Net Profits:

Amphastar Pharmaceuticals Inc’s net profit jumped 381.11% since last year same period to $24.25Mn in the Q1 2022. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated 22.74% jump in its net profits since last 3-months.

Net Profit Margins:

Amphastar Pharmaceuticals Inc’s net profit margin jumped 311.77% since last year same period to 20.15% in the Q1 2022. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated 23.27% jump in its net profit margins since last 3-months.

PE Ratio:

Amphastar Pharmaceuticals Inc’s price-to-earnings ratio after this Q1 2022 earnings stands at 17.29.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Amphastar Pharmaceuticals Inc post its latest quarter earnings

EPS Estimate Current Quarter
0.36
EPS Estimate Current Year
0.36

Highlights

EPS Estimate Current Quarter:

Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.36 - a 0% jump from last quarter’s estimates.

EPS Estimate Current Year:

Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.36.

Key Ratios

Key ratios of the Amphastar Pharmaceuticals Inc post its Q1 2022 earnings

Earning Per Share (EPS)
0.47
Return on Assets (ROA)
0.09
Return on Equity (ROE)
0.19
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Amphastar Pharmaceuticals Inc’s earning per share (EPS) jumped 74.07% since last year same period to 0.47 in the Q1 2022. This indicates that the Amphastar Pharmaceuticals Inc has generated 74.07% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Amphastar Pharmaceuticals Inc’s return on assets (ROA) stands at 0.09.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Amphastar Pharmaceuticals Inc’s return on equity (ROE) stands at 0.19.

Dividend Per Share (DPS):

Amphastar Pharmaceuticals Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-10
0.36
0.47
30.56%

Company Information

Amphastar is a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin active pharmaceutical ingredient products. Most of the Company's finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Organisation
Amphastar Pharmaceuticals Inc
Headquarters
Rancho Cucamonga, California, US
Employees
1.98K
Industry
Health Technology
CEO
Jack Zhang